Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05274425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05274425 · ClinicalTrials.gov record · last posted 2026-07-31

A 24-week rPMS Study in Real-world Setting for Enerzair

Name: A 24-week rPMS Study in Real-world Setting for Enerzair — clinical trial record (NCT05274425)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhaseNot specified

SponsorNovartis Pharmaceuticals

Started2022-05-09

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This surveillance was designed as a prospective, open-label, multicenter, single-arm, non-interventional, observational study to evaluate the safety and effectiveness of Enerzair inhalation capsule for up to 24 weeks under routine clinical practice.

Protocol amendment history 4 changes detected by DataLookout

2026-08-01

Enrollment closed, study ongoing

2026-08-01

Enrollment increased: 600 → 683 participants

2026-08-01

Primary completion moved earlier: 2027-03-11 → 2026-12-23

2026-08-01

Completion moved earlier: 2027-03-11 → 2026-12-23

Trial Details

NCT Number	NCT05274425
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Asthma
Enrollment	683 participants
Start Date	2022-05-09
Primary Completion	2026-12-23 (estimated)
Study Completion	2026-12-23 (estimated)
Updated on ClinicalTrials.gov	2026-07-31